An Open Label Study to Assess the Effect of Euryco-10® Oral Dietary Supplement in Senior Men

Inclusion Criteria: Male ≥ 55 years of age Exclusion Criteria: Severe lower urinary tract symptoms. Current use of any herbal and/or nutritional supplements that can interfere with testosterone. A history of cancer except melanoma skin cancer. Currently receiving treatment with cancer chemotherapy or antiandrogens. Chronic use of systemic glucocorticoids (use within \>14 days up to the 3months prior to screening); use of non-testosterone anabolic steroids within12 months prior to screening. History of frequent opioid use \>1 time/week during any week within 30 days prior to screening. Have a history of known angina. Have a history of severe liver disease or clinical evidence of hepatic impairment at screening. Untreated severe obstructive sleep apnea. Allergies to any of the ingredients in Euryco-10® or BioPerine. Any condition which would interfere with the subject's ability to provide informed consent, to comply with study instructions, or which might confound the interpretation of the study results